Hiroji Oida
Impact in
- Pharmacology top 0.5%
- Inflammatory mediators and NSAID effects
- Biochemistry top 1%
- Eicosanoids and Hypertension Pharmacology
Papers in
- Pharmacology 10
- Inflammatory mediators and NSAID effects 10
-
- Receptor Mechanisms and Signaling 4
- Co-authors
- Shuh Narumiya (8 shared papers)Yukihiko Sugimoto (7 shared papers)Fumitaka Ushikubi (5 shared papers)Atsushi Ichikawa (5 shared papers)Masahiko Negishi (3 shared papers)Eri Segi‐Nishida (3 shared papers)Yoshiya Aze (3 shared papers)T. Nishimura (2 shared papers)
- Journals
- Journal of Clinical Investigation (2 papers)Bioorganic & Medicinal Chemistry (2 papers)Biochemical and Biophysical Research Communications (1 paper)Proceedings of the National Academy of Sciences (1 paper)British Journal of Pharmacology (1 paper)
- Partner nations
- JapanRussiaUnited Kingdom
In The Last Decade
Hiroji Oida
18 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 96
- Pharmacology 928
- Biochemistry 374
- Genetics 376
- Physiology 311
- Immunology 249
Countries citing papers authored by Hiroji Oida
This map shows the geographic impact of Hiroji Oida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroji Oida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroji Oida more than expected).
Fields of papers citing papers by Hiroji Oida
This network shows the impact of papers produced by Hiroji Oida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroji Oida. The network helps show where Hiroji Oida may publish in the future.
Co-authors
The 25 scholars most cited alongside Hiroji Oida, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 494 | |
| 2 | 2004 | 309 | |
| 3 | 2002 | 274 | |
| 4 | 1998 | 264 | |
| 5 | 1994 | 221 | |
| 6 | 1995 | 186 | |
| 7 | 1997 | 84 | |
| 8 | 2004 | 73 | |
| 9 | 1997 | 55 | |
| 10 | The regional distribution and cellular localization of mRNA encoding rat prostacyclin synthase. | 1997 | 39 |
| 11 | 2005 | 28 | |
| 12 | 2012 | 18 | |
| 13 | 2010 | 18 | |
| 14 | Hormone-induced apoptosis by Fas-nuclear receptor fusion proteins: novel biological tools for controlling apoptosis in vivo. | 1996 | 17 |
| 15 | Intratumoral tumor necrosis factor induction and tumor growth suppression by ONO-4007, a low-toxicity lipid A analog. | 1999 | 10 |
| 16 | 2012 | 8 | |
| 17 | 2011 | 8 | |
| 18 | 2013 | 4 | |
| 19 | 1995 | 0 |
About Hiroji Oida
Hiroji Oida is a scholar working on Pharmacology, Molecular Biology, Organic Chemistry, Cellular and Molecular Neuroscience and Oncology, having authored 19 papers that have together received 2.1k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (10 papers), Receptor Mechanisms and Signaling (4 papers), Eicosanoids and Hypertension Pharmacology (3 papers), Bone health and treatments (3 papers), Cancer, Lipids, and Metabolism (2 papers), Organometallic Compounds Synthesis and Characterization (2 papers), Crystal structures of chemical compounds (2 papers) and Neuropeptides and Animal Physiology (2 papers). The work is most often cited by research in Pharmacology (928 citations), Biochemistry (374 citations), Genetics (376 citations), Physiology (311 citations) and Immunology (249 citations). Hiroji Oida has collaborated with scholars based in Japan, Russia and United Kingdom. Frequent co-authors include Shuh Narumiya, Yukihiko Sugimoto, Fumitaka Ushikubi, Atsushi Ichikawa, Masahiko Negishi, Eri Segi‐Nishida, Yoshiya Aze, T. Nishimura, A. Yamasaki and Takashi Tanaka. Their work appears in journals such as Journal of Clinical Investigation, Bioorganic & Medicinal Chemistry, Biochemical and Biophysical Research Communications, Proceedings of the National Academy of Sciences and British Journal of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.